Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Head & Neck 1Breast 1

Conditions

Neoplasms 1Head and Neck Neoplasms 1Breast Neoplasms 1Anxiety Disorders 1

Interventions

Cyclophosphamide 3162Cisplatin 3160Carboplatin 2938Paclitaxel 2673Radiotherapy 2648Gemcitabine 2547pembrolizumab 2331Docetaxel 2157Bevacizumab 2128Fluorouracil 1822Capecitabine 1784Oxaliplatin 1713Dexamethasone 1590Nivolumab 1517Doxorubicin 1477Rituximab 1454Etoposide 1342Magnetic Resonance Spectroscopy 1266Irinotecan 1235Leucovorin 1216Cytarabine 1123Pemetrexed 1062Drug Therapy 1062fludarabine 1050Vincristine 956Specimen Handling 936Prednisone 926Cetuximab 921Lenalidomide 916Trastuzumab 902

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Virtual Reality Exposure Therapy × Clear all
NCT05135260 2024-10-16

Virtual Reality on Pain, Stress, and Affect in the Infusion Clinic

Vanderbilt-Ingram Cancer Center

Phase NA Completed
99 enrolled
Tumor-Agnostic

Neoplasms

NCT04419077 2023-09-05

REV

Hospices Civils de Lyon

Phase NA Completed
41 enrolled
BreastHead & Neck

Anxiety Disorders, Breast Neoplasms, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡